Does anyone have any idea if MHRA has a mechanism for interim analysis, and, if so, does a protocol exist to have one exist for CD12? I realize they are basically piggy backing onto our FDA trial so I don’t know if this is even possible. What I’m asking is, assuming we are advised to continue the trial by the DSMC, could/should Cytodyn request an interim analysis By MHRA at 250 or 300 enrolled?